A Phase II Clinical Study of Stereotactic Radiation Therapy in Patients With High-risk Prostate Cancer

Clinical trial NCT05430737 · UNKNOWN

Trial details

NCT number: NCT05430737
Sponsor: West China Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Prostate Cancer Stereotactic Body Radiotherapy High-risk Efficacy Safety

Start date: 2022-06-30
Primary completion: 2025-06-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.